In this study, all MDD groups, control groups, and remission groups belonging to the discovery set and validation set were 26 or more each, so the minimum criterion to confirm the statistical significance of each group comparison was satisfied
A Lilly sales rep could go to the doctor and say, Look, our competitor is saying that our drug is better. Approvals to watch for Company : Novo Nordisk Molecule : CagriSema Mode of action : Targets GLP-1, amylin, and calcitonin receptors Modality : Once-weekly injection Company : Structure Therapeutics Molecule : Aleniglipron Mode of action : Targets GLP-1 receptors Modality : Once-daily pill Company : Eli Lilly and Company Molecule : Retatrutide Mode of action : Targets GLP-1, GIP, and glucagon receptors Modality : Once-weekly injections Note: GLP-1 means glucagon-like peptide 1, and GIP means gastric inhibitory polypeptide
All OptPeptide products are for laboratory research use only
40, 2023, p
The NAION incidence was 20 events in the semaglutide group compared to 3 in the non-GLP-1 RA group
Autism Spectrum Disorder 12
